MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
about
Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 StimulationMicroRNA-Mediated Down-Regulation of Apoptosis Signal-Regulating Kinase 1 (ASK1) Attenuates the Apoptosis of Human Mesenchymal Stem Cells (MSCs) Transplanted into Infarcted Heart.Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy.Urinary exosome-derived microRNAs reflecting the changes of renal function and histopathology in dogs.Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury.Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype - Role of Risk Factors and Epigenetics.Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cells.MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target.Therapeutic application of extracellular vesicles in kidney disease: promises and challenges.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.What can target kidney fibrosis?Messenger RNA Life-Cycle in Cancer Cells: Emerging Role of Conventional and Non-Conventional RNA-Binding Proteins?The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.The Lhx1-Ldb1 complex interacts with Furry to regulate microRNA expression during pronephric kidney developmentMicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection
P2860
Q33734913-AB80A115-92BA-4DCF-BD93-031A3BD3A11FQ37377527-2AC51F1F-A026-417D-B280-5378794D610FQ37493523-4FC7F3AC-6DAA-41C8-9221-3941BF1FE5A5Q37578916-49E292B5-9798-40C4-B6EF-1816C860C9EBQ39111132-ABAF128F-B353-4568-87B2-94C27ADB42FAQ41333737-224E9199-18F4-49C1-9F38-D7622C38F3BEQ42371463-13D25547-4C5C-462E-B62C-C646D3A3E072Q47654194-919E27B8-6B04-4936-8A15-C77FF85EEA7CQ48105132-C749D5A2-85A8-49A2-929E-E2415245BAC2Q50063239-80901C39-F4C2-423A-9F4D-128A545053C3Q51066092-A9793AF5-1747-4AB9-A8BA-E3E834F12E51Q52370800-0364F6DD-1D11-4D08-9BB4-81F89783A025Q52688968-846DDD2D-2F4B-44BE-91B2-11108B346700Q58099129-C0EA05BA-3C9D-4AB8-BAE2-02217D05FAA9Q58787180-9B2E315A-FE75-4AD1-8915-646165D2DA03
P2860
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
@en
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
@nl
type
label
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
@en
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
@nl
prefLabel
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
@en
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
@nl
P2093
P2860
P1476
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.
@en
P2093
Ivan G Gomez
Jeremy S Duffield
Naoki Nakagawa
P2860
P304
P356
10.1152/AJPRENAL.00523.2015
P577
2016-02-24T00:00:00Z